Agios Pharmaceuticals Inc (NAS:AGIO)
$ 58.945 -0.075 (-0.13%) Market Cap: 3.36 Bil Enterprise Value: 2.42 Bil PE Ratio: 5.19 PB Ratio: 2.07 GF Score: 37/100

Q3 2023 Agios Pharmaceuticals Inc Earnings Call Transcript

Nov 02, 2023 / 12:00PM GMT
Release Date Price: $21 (-1.41%)
Operator

Good day, and thank you for standing by. Welcome to the Agios Pharmaceuticals, Inc. Quarter 3 2023 Earnings Conference Call.

(Operator Instructions)

Please be advised that today's conference is being recorded. I would now like to hand the conference over to Mr. Chris Taylor, VP Investor Relations and Corporate Communications. Please go ahead.

Christopher J. M. Taylor
Agios Pharmaceuticals, Inc. - VP of IR & Corporate Communications

Thank you, operator. Good morning, everyone, and welcome to Agios Third Quarter 2023 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com. On today's call, I am joined by our Chief Executive Officer, Brian Goff; Dr. Sarah Gheuens, Chief Medical Officer and Head of Research and Development; Tsveta Milanova, our Chief Commercial Officer; and Cecilia Jones, Chief Financial Officer.

Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot